Medical Condition News

RSS

Employees who face high emotional demand, conflicting roles are more likely to report psychological distress

Employees who face high emotional demand and conflicting roles are more likely to report psychological distress—placing them at higher risk of mental health disorders and reduced productivity, reports a study in the June Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

4 Jun 2013

Integrity Applications' GlucoTrack DF-F glucose monitoring device gets CE Mark approval

Integrity Applications, Inc. announced today that it has received CE Mark approval for its GlucoTrack DF-F non-invasive blood glucose measurement device.

4 Jun 2013

New technique selectively represses unwanted immune reactions without disabling immune system

The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have major drawbacks, but a team from The Scripps Research Institute (TSRI) has demonstrated a new technique that may lead to a better way to selectively repress unwanted immune reactions without disabling the immune system as a whole.

4 Jun 2013

Tel Aviv University researchers find protein modification may help control Alzheimer's and epilepsy

In the brain, cell-to-cell communication is dependent on neurotransmitters, chemicals that aid the transfer of information between neurons. Several proteins have the ability to modify the production of these chemicals by either increasing or decreasing their amount, or promoting or preventing their secretion.

4 Jun 2013

OxThera granted Japanese patents for treating oxalate-related disease

OxThera AB has been granted three Japanese patents during 2012 and 2013. The patents will secure the pharmaceutical composition and the method for treating and preventing oxalate-related disease with micro-organisms and enzymes and will further strengthen the Company's patent estate for this unmet medical need.

4 Jun 2013

Assistive robotic technologies for people with dementia, other age-related disabilities

With a rapidly ageing population, the number of people with dementia and other age-related disabilities is expected to soar by 2050.

4 Jun 2013

Researchers solve long-standing mystery behind dormant disseminated breast tumor cells

The long-standing mystery behind dormant disseminated breast tumor cells and what activates them after years and even decades of latency may have been solved. Researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) have identified the microenvironment surrounding microvasculature - the small blood vessels that transport blood within tissues - as a niche where dormant cancer cells reside. When these blood vessels begin to sprout, the new tips produce molecules that transform dormant cancer cells into metastatic tumors.

4 Jun 2013

Study examines link between IL-17F and treatment response to interferon beta-1b in multiple sclerosis patients

A study by Hans-Peter Hartung, M.D., of Heinrich-Heine-Universität, Düsseldoft, Germany, and colleagues examines the association between IL-17F and treatment response to interferon beta-1b among patients with relapsing-remitting multiple sclerosis.

4 Jun 2013

Study examines efficacy of dietary flaxseed supplementation in management of hypercholesterolemia in children

A study by Helen Wong, R.D., of The Hospital for Sick Children, Ontario, Canada, and colleagues examined the safety and efficacy of dietary flaxseed supplementation in the management of hypercholesterolemia (high levels of cholesterol) in children.

4 Jun 2013

Racial and ethnic disparities in obese children may be determined by risk factors in infancy

Racial and ethnic disparities in children who are overweight and obese may be determined by risk factors in infancy and early childhood, according to a study published Online First by JAMA Pediatrics, a JAMA Network publication.

4 Jun 2013

Researchers establish link between abnormal structure of synapses and behavioral abnormalities of brain circuits in FXS

Fragile X syndrome (FXS) is a genetic malady that is the most common inherited cause of autism and intellectual disability. Brain scientists know the gene defect that causes FXS, and the damage it does-- misshaping the brain's synapses, the connections between neurons. But how that abnormal shaping of synapses translates to abnormal behavior is unclear.

4 Jun 2013

Study brings researchers one step closer to personalized colorectal cancer treatment

MET protein levels correlate strongly with epithelial-mesenchymal transition phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.

4 Jun 2013

NAPHS lauds Administration's initiative to launch national dialogue on mental health

"The National Association of Psychiatric Health Systems and its members applaud the Administration's launch today of a national dialogue on mental health," said NAPHS President and CEO Mark Covall.

4 Jun 2013

Cardiovascular disease: The leading cause of death in UK

Cardiovascular disease is the leading cause of death in the UK, accounting for a third of all fatalities through illnesses such as stroke and heart disease.

4 Jun 2013

Debiopharm evaluates Debio 1143 in combination with Carboplatin and Paclitaxel in NSCLC patients

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced it treated its first patients in a phase I study of Debio 1143 combined with Carboplatin and Paclitaxel in patients with squamous non-small cell lung cancer, platinum-refractory ovarian cancer, and basal-like/claudin low triple negative breast cancer.

4 Jun 2013

Cancer immunotherapy shows promise in treating patients with metastatic tumors

Cancer immunotherapy is showing promise in treating patients with a variety of advanced, metastatic tumors, as evidenced by two newly unveiled studies from Yale Cancer Center.

4 Jun 2013

OncoMed Pharmaceuticals highlights new data for vantictumab at ASCO meeting

OncoMed Pharmaceuticals, Inc., a privately held, clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor-initiating cells, today highlighted new data for vantictumab, a monoclonal antibody targeting the Wnt pathway, at a poster session at the Annual Meeting of the American Society for Clinical Oncology in Chicago, IL.

4 Jun 2013

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

Highly educated individuals with mild cognitive impairment that later progressed to Alzheimer's disease cope better with the disease than individuals with a lower level of education in the same situation, according to research published in the June issue of The Journal of Nuclear Medicine.

4 Jun 2013

Physicians call for tax hike on tobacco, alcoholic beverages; new tax on sugary drinks, fatty foods

Go ye and sin no more -- or pay for it, when it comes to junk food, smoking and consuming alcohol. That's the message from two Mayo Clinic physicians who say raising "sin" taxes on tobacco and alcoholic beverages and imposing them on sugary drinks and fatty foods would lead many people to cut back, improving public health.

4 Jun 2013

Precision Biologics reports findings from Phase I/IIA study of NPC-1C at ASCO meeting

Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.

4 Jun 2013

Medical Condition News

Employees who face high emotional demand, conflicting roles are more likely to report psychological distress

Integrity Applications' GlucoTrack DF-F glucose monitoring device gets CE Mark approval

New technique selectively represses unwanted immune reactions without disabling immune system

Tel Aviv University researchers find protein modification may help control Alzheimer's and epilepsy

OxThera granted Japanese patents for treating oxalate-related disease

Assistive robotic technologies for people with dementia, other age-related disabilities

Researchers solve long-standing mystery behind dormant disseminated breast tumor cells

Study examines link between IL-17F and treatment response to interferon beta-1b in multiple sclerosis patients

Study examines efficacy of dietary flaxseed supplementation in management of hypercholesterolemia in children

Racial and ethnic disparities in obese children may be determined by risk factors in infancy

Researchers establish link between abnormal structure of synapses and behavioral abnormalities of brain circuits in FXS

Study brings researchers one step closer to personalized colorectal cancer treatment

NAPHS lauds Administration's initiative to launch national dialogue on mental health

Cardiovascular disease: The leading cause of death in UK

Debiopharm evaluates Debio 1143 in combination with Carboplatin and Paclitaxel in NSCLC patients

Cancer immunotherapy shows promise in treating patients with metastatic tumors

OncoMed Pharmaceuticals highlights new data for vantictumab at ASCO meeting

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

Physicians call for tax hike on tobacco, alcoholic beverages; new tax on sugary drinks, fatty foods

Precision Biologics reports findings from Phase I/IIA study of NPC-1C at ASCO meeting

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News